These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13332285)

  • 41. Single-dose therapy of chancroid with trimethoprim-sulfametrole.
    Plummer FA; Nsanze H; D'Costa LJ; Karasira P; Maclean IW; Ellison RH; Ronald AR
    N Engl J Med; 1983 Jul; 309(2):67-71. PubMed ID: 6343878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular characterization of Haemophilus ducreyi strains from Jackson, Mississippi, and New Orleans, Louisiana.
    Haydock AK; Martin DH; Morse SA; Cammarata C; Mertz KJ; Totten PA
    J Infect Dis; 1999 Jun; 179(6):1423-32. PubMed ID: 10228064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States.
    Chen CY; Mertz KJ; Spinola SM; Morse SA
    J Infect Dis; 1997 Jun; 175(6):1390-5. PubMed ID: 9180178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial therapy of chancroid: effectiveness of erythromycin.
    Plummer FA; D'Costa LJ; Nsanze H; Maclean IW; Karasira P; Piot P; Fast MV; Ronald AR
    J Infect Dis; 1983 Oct; 148(4):726-31. PubMed ID: 6355314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi.
    Ndinya-Achola JO; Kihara AN; Fisher LD; Krone MR; Plummer FA; Ronald A; Holmes KK
    Int J STD AIDS; 1996; 7(3):201-5. PubMed ID: 8799783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation of H. ducreyi (a preliminary communication).
    Kumari S; Agarwal DS; Singh R
    Indian J Pathol Microbiol; 1979 Jul; 22(3):207-9. PubMed ID: 317492
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of culture media for the laboratory diagnosis of chancroid.
    Pillay A; Hoosen AA; Loykissoonlal D; Glock C; Odhav B; Sturm AW
    J Med Microbiol; 1998 Nov; 47(11):1023-6. PubMed ID: 9822303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asymptomatic carriage of Haemophilus ducreyi confirmed by the polymerase chain reaction.
    Hawkes S; West B; Wilson S; Whittle H; Mabey D
    Genitourin Med; 1995 Aug; 71(4):224-7. PubMed ID: 7590712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European guideline for the management of chancroid, 2011.
    Kemp M; Christensen JJ; Lautenschlager S; Vall-Mayans M; Moi H
    Int J STD AIDS; 2011 May; 22(5):241-4. PubMed ID: 21571970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The development of specific rRNA-derived oligonucleotide probes for Haemophilus ducreyi, the causative agent of chancroid.
    Rossau R; Duhamel M; Jannes G; Decourt JL; Van Heuverswyn H
    J Gen Microbiol; 1991 Feb; 137(2):277-85. PubMed ID: 1707945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conjunctivitis due to Haemophilus ducreyi infection.
    Gregory JE; Henderson RW; Smith R
    Br J Vener Dis; 1980 Dec; 56(6):414. PubMed ID: 6969619
    [No Abstract]   [Full Text] [Related]  

  • 53. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
    Purcell BK; Richardson JA; Radolf JD; Hansen EJ
    J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
    Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
    Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid.
    Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD
    J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nutritional studies of a virulent strain of Haemophilus ducreyi.
    AJELLO GW; DEACON WE; PAUL L; WALLS KW
    J Bacteriol; 1956 Dec; 72(6):802-8. PubMed ID: 13398367
    [No Abstract]   [Full Text] [Related]  

  • 57. Study of Ducrey's bacillus and recognition of a gram-positive smooth phase.
    DEACON WE; ALBRITTON DC; EDMUNDSON WF; OLANSKY S
    Proc Soc Exp Biol Med; 1954 Jun; 86(2):261-4. PubMed ID: 13177648
    [No Abstract]   [Full Text] [Related]  

  • 58. V.D.R.L. chancroid studies. III. Use of Ducrey skin test vaccines on rabbits.
    KAPLAN W; DEACON WE; OLANSKY S; ALBRITTON DC
    J Invest Dermatol; 1956 May; 26(5):415-9. PubMed ID: 13332287
    [No Abstract]   [Full Text] [Related]  

  • 59. Diagnostic tests for chancroid.
    Lewis DA
    Sex Transm Infect; 2000 Apr; 76(2):137-41. PubMed ID: 10858718
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevalence of, antibody response to, and immunity induced by Haemophilus ducreyi hemolysin.
    Dutro SM; Wood GE; Totten PA
    Infect Immun; 1999 Jul; 67(7):3317-28. PubMed ID: 10377108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.